Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02294019
Other study ID # B3491013
Secondary ID AUT
Status Completed
Phase Phase 3
First received November 14, 2014
Last updated June 24, 2015
Start date November 2014
Est. completion date May 2015

Study information

Verified date June 2015
Source Pfizer
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

This is an open label, multicenter, 30 day study designed to mimic an OTC like environment in which subjects will use the product after making a purchase decision about ibuprofen 400 mg caplets based only on their reading of the Drug Facts Label (DFL) and other information on the package.


Recruitment information / eligibility

Status Completed
Enrollment 738
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male or female at least 18 years of age (19 years of age in Alabama)

- Subject reports taking over-the-counter (OTC) analgesics for pain or fever relief

Exclusion Criteria:

- Current government-issued identification (ID)

- Pregnant or breastfeeding females

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Drug:
Ibuprofen 400 mg caplet
400 milligram (mg) caplet according to Drug Facts label

Locations

Country Name City State
United States Phil's Pills, Inc. Albuquerque New Mexico
United States Goodrich Pharmacy Andover Minnesota
United States Goodrich Pharmacy Anoka Minnesota
United States Family Prescription Center Bethlehem Pennsylvania
United States Goodrich Pharmacy Blaine Minnesota
United States The Medicine Shoppe Bountiful Utah
United States Kroger Pharmacy #342 Cary North Carolina
United States Sutton Family Pharmacy Dalton Georgia
United States Goodrich Pharmacy Elk River Minnesota
United States Foothills Compounding Pharmacy Enumclaw Washington
United States Garden Drug Fort Lauderdale Florida
United States Wynn's Pharmacy Inc. Griffin Georgia
United States Robert's Discount Pharmacy Hoover Alabama
United States Albers' Specialty Pharmacy Kansas City Missouri
United States Ostrom Drugs Kenmore Washington
United States Northview Pharmacy Layton Utah
United States Pharmacy at the Pig McCalla Alabama
United States Community Clinical Pharmacy Mesa Arizona
United States Texas Road Pharmacy Monroe New Jersey
United States Pill Box Pharmacy and Medical Supply Pembroke Pines Florida
United States Summerfield Pharmacy Riverview Florida
United States Countryside Pharmacy Savannah Missouri
United States Cub Pharmacy Number 1924 St. Louis Park Minnesota
United States Total Health and Wellness Center of Taos Taos New Mexico
United States Family Plaza Pharmacy West Jordan Utah

Sponsors (1)

Lead Sponsor Collaborator
Pfizer

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of participants taking greater than 3 caplets on no more than 2 use days 30 days No
Secondary Percentage of participants taking greater than 1 caplet at a time 30 days No
See also
  Status Clinical Trial Phase
Recruiting NCT03667911 - Virtual Reality Videos in Improving Bowel Preparation Quality of Colonoscopy N/A
Completed NCT05297188 - The Effect of Ergonomic Sleep Mask Usage on Patients' Sleep Quality and Comfort
Completed NCT03264937 - Social-software iMproving wARfarin Therapy N/A
Completed NCT02742740 - Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials N/A
Completed NCT04291807 - Video Assisted Education Before ERCP N/A
Completed NCT03220204 - Researching Emotions And Cardiac Health: Phase III N/A
Completed NCT02669355 - Effect of Wearing of White Coat on Patient Satisfaction in Indian Out Patient Department (OPD) Setting N/A
Completed NCT02756949 - Smart Linkage-to-HIV Care Via a Smartphone App N/A
Completed NCT03147716 - Parent Engagement Package: Comparing Strategies for Engaging Parents Into Parenting Programs N/A
Completed NCT01568515 - Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students Phase 0
Recruiting NCT06092281 - Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD N/A
Completed NCT03125668 - Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin N/A
Recruiting NCT03753035 - Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children
Completed NCT05331820 - The Influence of Weekly Reminders on Enhancing Patient Compliance in Patients With Fixed Orthodontic Treatment N/A
Not yet recruiting NCT02301923 - Continuous Positive Airway Pressure (CPAP) Compliance in Obstructive Sleep Apnea N/A
Completed NCT01897870 - The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge. N/A
Completed NCT01752595 - The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment N/A
Completed NCT01559805 - Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men N/A
Active, not recruiting NCT01454830 - Tailored Intervention to Promote Positive Airway Pressure Adherence Phase 1
Completed NCT01174706 - Impact of Information Prescriptions on Medication Adherence in Emergency Department (ED) Patients N/A